Filing Flows › Medline (MDLN) › Q3 2026
Medline (MDLN) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 4, 2026
Medline (MDLN) reported revenue of $7.9B for the third quarter 2026 (Q3 2026), +10% from a year earlier and +2% from the quarter before. Operating margin was 6.4%, net earnings $198M (2.5% of revenue).
Medline, Q3 2026: revenue $7.9B (+10% year over year), operating margin 6.4%, net earnings $198M, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.9B | +2% | +10% |
| Gross profit | $1.9B | -13% | +3% |
| Operating profit | $500M | +27% | -13% |
| Net earnings | $198M | +236% | -38% |
| Operating cash flow | $1.0B | +43% | +61% |
| Free cash flow | $884M | +46% | +65% |
What changed
Revenue was $7.9B in Q3 2026, up 10% year over year and up 2% from the previous quarter.
Gross margin was 24.5%, down 1.8 points from a year earlier. Operating profit was $0.50B, a 6.4% margin (down 1.7 points year over year). Operating profit fell $0.07B even though revenue rose $0.74B versus a year earlier, so costs grew faster than sales. Operating expenses grew 10% against revenue growth of 10%. The fastest-growing cost line was SG&A (+13%). Net earnings were $0.20B, down 38% year over year. The effective tax rate was 17.6%.
Operating cash flow was $1.0B (up 61% year over year), 322% of net income including minority interests. Non-cash charges added back $0.26B of depreciation and amortization and $0.03B of share-based compensation. Working capital and other items added $0.42B. Capital expenditures of $0.14B left free cash flow of $0.88B.
Questions
What was Medline's revenue in the third quarter 2026?
Medline (MDLN) reported revenue of $7.9B for the third quarter 2026 (Q3 2026), +10% from a year earlier and +2% from the quarter before.
Was Medline profitable in the third quarter 2026?
Operating profit was $500M (6.4% of revenue) and net earnings $198M.
Source: Medline 10-Q on SEC EDGAR.